ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.
Doctors call for whooping cough vaccination uptake amid worst year on record for cases
Approximately 130 confirmed cases of whooping cough (pertussis) have been recorded each day on average in 2024, according to ...